Mahmoud F. Abo-Ashour
Mahmoud F. Abo-Ashour publishes mostly in Organic Chemistry, Molecular Biology and Pharmacology, on topics such as Enzyme function and inhibition, Synthesis and Catalytic Reactions and Synthesis and biological activity.
- World rank
- #583,533 of 7,710,434 ranked researchers
- Rank in Egypt
- #1,331 of 36,277
- Works
- 26
- Citations
- 1.3k
- Citations per work
- 50.9
What does Mahmoud F. Abo-Ashour research?
Mahmoud F. Abo-Ashour's work is mostly in Chemistry (55%), Biochemistry, Genetics and Molecular Biology (28%), Medicine (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1555.9%
- Chemistry1454.6%
- Computer Science01.3%
- Life Sciences829.3%
- Health Sciences312.0%
- Medicine312.0%
- Everything else12.8%
- 1Organic Chemistry49% of their works
- 2Molecular Biology28% of their works
- 3Pharmacology12% of their works
- 4Physical and Theoretical Chemistry5% of their works
- 5Toxicology1% of their works
- 6Computational Theory and Mathematics1% of their works
Research topics
- Enzyme function and inhibition
- Synthesis and Catalytic Reactions
- Synthesis and biological activity
- Cholinesterase and Neurodegenerative Diseases
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Characterization of Heterocyclic Compounds
- Chemical Reactions and Mechanisms
- Synthesis and Biological Evaluation
Which keywords describe Mahmoud F. Abo-Ashour's research?
The keywords of their largest research topics: Anticancer Agents, Medicinal Chemistry, Synthesis, Drug Discovery, Amination, Carbonic Anhydrases, Catalytic and Inhibitors.
- Quinoxaline
- Tunneling Control
- Scaffold
- Chemical Reactions
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Anticancer
- Tubulin Inhibitors
- Inhibitors
- Carbonic Anhydrases
- Drug Discovery
- Medicinal Chemistry
- Anticancer Agents
- Synthesis
- Amination
- Catalytic
- Heterocyclic Compounds
- Vascular Targeting Agents
- Antimicrobial
- Biological Evaluation
- Biological Activities
- Phenothiazines
- Triazines
- Antimicrobial Activity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Anticancer Agents273 topics
- Medicinal Chemistry273 topics
- Synthesis264 topics
- Drug Discovery192 topics
- Amination151 topic
- Carbonic Anhydrases151 topic
- Catalytic151 topic
- Inhibitors151 topic
- Heterocyclic Compounds122 topics
- Tubulin Inhibitors91 topic
- Vascular Targeting Agents91 topic
- Anticancer82 topics
- Antimicrobial82 topics
- Acetylcholinesterase71 topic
- Biological Evaluation72 topics
- Cholinesterase Inhibitors71 topic
- Biological Activities41 topic
- Chemical Reactions41 topic
- Phenothiazines41 topic
- Scaffold41 topic
- Triazines41 topic
- Tunneling Control41 topic
- Antimicrobial Activity31 topic
- Quinoxaline31 topic
Where does Mahmoud F. Abo-Ashour work?
Mahmoud F. Abo-Ashour's main affiliation in the publication record is Egyptian Russian University, Egypt.
How many publications and citations does Mahmoud F. Abo-Ashour have?
OpenAlex counts 26 works and 1,323 citations for Mahmoud F. Abo-Ashour, an h-index of 18, ranking #583,533 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mahmoud F. Abo-Ashour. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.